...
search icon
pepg-img

PepGen Ltd, Common Stock

PEPG

NSQ

$1.6

+$0.07

(4.58%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$49.69M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
142.84K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.42
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.88 L
$19.3 H
$1.6

About PepGen Ltd, Common Stock

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and PGN-EDO53, which is in preclinical trial to treat duchenne muscular dystrophy. The company was founded in 2018 and is based in Boston, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FramePEPGSectorS&P500
1-Week Return5.26%4.13%7.14%
1-Month Return8.11%-4.48%-0.92%
3-Month Return-18.78%-5.78%-8.95%
6-Month Return-79.03%-7.23%-5.21%
1-Year Return-86.3%-1.69%7.95%
3-Year Return-87.59%3.23%28.74%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue110.00K178.00K493.00K1.18M-[{"date":"2020-12-31","value":9.29,"profit":true},{"date":"2021-12-31","value":15.03,"profit":true},{"date":"2022-12-31","value":41.64,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(110.00K)(178.00K)(493.00K)(1.18M)-[{"date":"2020-12-31","value":-11000000,"profit":false},{"date":"2021-12-31","value":-17800000,"profit":false},{"date":"2022-12-31","value":-49300000,"profit":false},{"date":"2023-12-31","value":-118400000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses1.88M27.11M68.30M84.77M97.74M[{"date":"2020-12-31","value":1.92,"profit":true},{"date":"2021-12-31","value":27.74,"profit":true},{"date":"2022-12-31","value":69.88,"profit":true},{"date":"2023-12-31","value":86.73,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(1.88M)(27.11M)(68.30M)(84.77M)(97.74M)[{"date":"2020-12-31","value":-187700000,"profit":false},{"date":"2021-12-31","value":-2710900000,"profit":false},{"date":"2022-12-31","value":-6830100000,"profit":false},{"date":"2023-12-31","value":-8476600000,"profit":false},{"date":"2024-12-31","value":-9773900000,"profit":false}]
Total Non-Operating Income/Expense(4.00K)(163.00K)5.70M12.61M7.14M[{"date":"2020-12-31","value":-0.03,"profit":false},{"date":"2021-12-31","value":-1.29,"profit":false},{"date":"2022-12-31","value":45.16,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":56.62,"profit":true}]
Pre-Tax Income(1.89M)(27.28M)(65.40M)(78.55M)(90.60M)[{"date":"2020-12-31","value":-188900000,"profit":false},{"date":"2021-12-31","value":-2728100000,"profit":false},{"date":"2022-12-31","value":-6539800000,"profit":false},{"date":"2023-12-31","value":-7855300000,"profit":false},{"date":"2024-12-31","value":-9059800000,"profit":false}]
Income Taxes(8.00K)(58.56K)3.71M73.00K617.00K[{"date":"2020-12-31","value":-0.22,"profit":false},{"date":"2021-12-31","value":-1.58,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":1.97,"profit":true},{"date":"2024-12-31","value":16.65,"profit":true}]
Income After Taxes(1.88M)(27.22M)(69.10M)(78.63M)(91.22M)[{"date":"2020-12-31","value":-188100000,"profit":false},{"date":"2021-12-31","value":-2722244200,"profit":false},{"date":"2022-12-31","value":-6910400000,"profit":false},{"date":"2023-12-31","value":-7862600000,"profit":false},{"date":"2024-12-31","value":-9121500000,"profit":false}]
Income From Continuous Operations(1.89M)(27.28M)(69.10M)(78.63M)(89.98M)[{"date":"2020-12-31","value":-188900000,"profit":false},{"date":"2021-12-31","value":-2728100000,"profit":false},{"date":"2022-12-31","value":-6910400000,"profit":false},{"date":"2023-12-31","value":-7862600000,"profit":false},{"date":"2024-12-31","value":-8998100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(1.88M)(27.28M)(69.10M)(78.63M)(89.98M)[{"date":"2020-12-31","value":-188100000,"profit":false},{"date":"2021-12-31","value":-2728100000,"profit":false},{"date":"2022-12-31","value":-6910400000,"profit":false},{"date":"2023-12-31","value":-7862600000,"profit":false},{"date":"2024-12-31","value":-8998100000,"profit":false}]
EPS (Diluted)-(0.90)(21.20)(3.30)(2.84)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-90,"profit":false},{"date":"2022-12-31","value":-2120,"profit":false},{"date":"2023-12-31","value":-330,"profit":false},{"date":"2024-12-31","value":-284,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PEPG
Cash Ratio 7.20
Current Ratio 7.41

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PEPG
ROA (LTM) -41.56%
ROE (LTM) -79.26%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PEPG
Debt Ratio Lower is generally better. Negative is bad. 0.21
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.79

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PEPG
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.42
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is PepGen Ltd share price today?

PepGen Ltd (PEPG) share price today is $1.6

Can Indians buy PepGen Ltd shares?

Yes, Indians can buy shares of PepGen Ltd (PEPG) on Vested. To buy PepGen Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PEPG stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of PepGen Ltd be purchased?

Yes, you can purchase fractional shares of PepGen Ltd (PEPG) via the Vested app. You can start investing in PepGen Ltd (PEPG) with a minimum investment of $1.

How to invest in PepGen Ltd shares from India?

You can invest in shares of PepGen Ltd (PEPG) via Vested in three simple steps:

  • Click on Sign Up or Invest in PEPG stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in PepGen Ltd shares
What is PepGen Ltd 52-week high and low stock price?

The 52-week high price of PepGen Ltd (PEPG) is $19.3. The 52-week low price of PepGen Ltd (PEPG) is $0.88.

What is PepGen Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of PepGen Ltd (PEPG) is 0.42

What is the Market Cap of PepGen Ltd?

The market capitalization of PepGen Ltd (PEPG) is $49.69M

What is PepGen Ltd’s stock symbol?

The stock symbol (or ticker) of PepGen Ltd is PEPG

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top